Instalab
logoInstalab

Streptococcus pyogenes

Vaginal Swab Test
Investigate a rare bacterial cause of persistent vaginal soreness or discharge when common explanations don't fit.
4.9 (2,585 reviews)
Tested by US Biotek Laboratories
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Self-collect at home
Kit shipped directly to you
Get results
Explained with clear next steps, no medical jargon

Should you take a Streptococcus pyogenes test?

This test is most useful if any of these apply to you.

Dealing With Persistent Itching or Discharge
If usual treatments haven't helped, targeted testing may identify an uncommon cause alongside an examination.
Pregnant or Recently Postpartum With Symptoms
A swab may help identify the cause, but fever, worsening pelvic pain, or sudden illness needs prompt medical assessment.
Having Confirmed Infections That Keep Returning
Recurrent confirmed infection can warrant checking for carriage in you or close contacts; a swab alone cannot identify the source.

About Streptococcus pyogenes

Say you've treated what looked like a yeast infection more than once, and the itching, redness, and discharge keep coming back. Streptococcus pyogenes is one possible explanation. Adult genital infections have been documented, including cases initially mistaken for yeast, but finding the bacterium on a swab doesn't by itself establish that it's causing your symptoms. Published adult case.

What Your Result Measures

This result concerns Streptococcus pyogenes in material collected with a vaginal swab. The report expresses its amount in x10^5 CFU/ml. CFU stands for colony-forming units, a way of expressing bacterial quantity based on growth into colonies. The scale represents hundreds of thousands of these units per milliliter of the analyzed sample.

The available test information doesn't specify the measurement method. The unit alone cannot establish whether the laboratory counted growing bacteria or reported an estimate calibrated to that scale. The amount also depends on how the specimen was collected and processed; it isn't a count of all the bacteria in your vagina.

S. pyogenes is an established infectious organism, but using its numerical abundance on a vaginal microbiome panel to diagnose infection, predict severe illness, or monitor preventive health remains unvalidated. In an observational study of adult vaginal cultures, neither the amount of bacterial growth nor the Gram stain reliably distinguished symptomatic infection from symptom-free carriage. That study supports caution about interpreting quantity; it does not validate this panel's unspecified method. Vaginal-swab study.

Vulvovaginitis in Adult Women

Vulvovaginitis is inflammation of the vulva and vagina. S. pyogenes can cause discharge, redness, pain, burning, and itching. These symptoms overlap with yeast infection and other causes of irritation. Published adult cases have involved recent throat or skin infections in the household, sexual contact, and vaginal tissue changes associated with breastfeeding or menopause. These are possible clues, not requirements for the diagnosis. Review of adult cases.

In one community laboratory, S. pyogenes grew from 100 of roughly 4,500 to 5,000 adult vaginal swabs, about 2%. Most positive women had symptoms, but 15% had none. A hospital laboratory identified 20 positive samples among roughly 2,000 swabs; 5% of those women had no symptoms. Hospital cases were more often associated with pregnancy-related infection. These figures describe women selected for testing, so they aren't estimates for healthy women generally. Observational study.

Many commonly used vaginitis panels target bacterial vaginosis, Candida, and Trichomonas without including S. pyogenes. A negative result on one of those panels leaves this organism unassessed. Persistent symptoms can also come from skin conditions, irritation, or hormone-related tissue changes, so an examination remains part of identifying the cause. Vaginitis panel study, CDC diagnostic guidance.

Pregnancy, Delivery, and the Weeks After

S. pyogenes can cause infection of the uterine lining after childbirth and can spread to the bloodstream or deeper tissues. Severe infection can trigger shock and organ failure. Studies of pregnancy-associated disease describe serious illness and deaths, but they don't establish the chance of those outcomes after an isolated positive vaginal swab. A positive swab and invasive infection are different clinical findings. Pregnancy infection review.

Carriage appears uncommon in late pregnancy. One study found group A strep in about 3 per 10,000 screening cultures, compared with group B strep in about 1 in 5. Those were combined vaginal-rectal cultures from pregnant women, a different specimen and population from vaginal-only testing in adults generally. The study doesn't establish the accuracy of this quantitative panel. Original screening study.

The bacterium's features can influence disease. A laboratory study comparing isolates from invasive postpartum infections with genital isolates from women without symptoms found differences in genes involved in stress responses and attachment to tissue. This was research on cultured bacterial strains, not a way to predict your risk from the amount on a vaginal swab. Strain-comparison study.

Fever can be absent early in severe postpartum infection. One published case began with abdominal pain and initially reassuring examinations before the woman's condition deteriorated. The course of your symptoms matters even when an earlier examination or test was reassuring. Postpartum case report.

Girls Before Puberty

S. pyogenes is a recognized bacterial cause of vulvovaginitis before puberty, sometimes associated with throat or skin infection. But redness and itching in children also commonly come from irritation, moisture, or other causes. Pediatric evidence should not be used to assume that an adult vaginal panel is appropriate for a child. Pediatric clinical guidance.

An older study of vulval and vaginal cultures found winter clustering, with strain patterns suggesting links to respiratory infections in winter and skin infections in summer. A separate study in Hangzhou linked short-term nitrogen dioxide exposure with more positive cultures from the vaginal entrance in prepubertal girls. That observational association doesn't establish that pollution caused the infections or explain an individual adult's result. Seasonal study, Pediatric pollution study.

Why Infections Can Return

Reinfection from a close contact is one documented explanation for recurrence. In case reports, women and their partners carried matching strains at genital, throat, or intestinal sites. A vaginal result alone cannot identify where the organism came from, and recurrence can also require reassessment of the original diagnosis and treatment response. Family epidemiology report.

Sexual contact, including oral sex, has been implicated in some cases, while household transmission provides another route. A positive result doesn't establish sexual transmission or infidelity. Adult case report, Recurrent genital infection report.

When Results Can Be Misleading

  • Carriage and symptoms: S. pyogenes can be present without causing symptoms. Its detection needs to be interpreted with your symptoms, examination, and pregnancy or postpartum status.
  • A negative result: this means the organism wasn't detected in the collected sample. It cannot exclude infection elsewhere or guarantee that carriage won't occur later.
  • Group A and group B: Streptococcus agalactiae is the separate species targeted by group B strep pregnancy screening. Its result cannot substitute for this one.
  • Species identification: some Streptococcus dysgalactiae strains carry the group A marker. A Gambian study found that some isolates initially classified as group A streptococci were this other species. Species-specific identification matters. Original study.
  • Collection and processing: the sampled site, swab, transport conditions, and laboratory procedure can affect detection. Shared units don't make results from different methods interchangeable. Genital specimen guidance.
  • Recent antibiotics: treatment can reduce bacterial growth and affect culture results. The relevance to this panel depends on its method, which isn't specified. A negative result after antibiotics doesn't establish whether the organism caused your earlier symptoms. Microbiology collection guidance.

What Moves This Biomarker

Evidence-backed interventions that affect your Streptococcus pyogenes level

↓ Decrease
Oral penicillin or amoxicillin for confirmed, uncomplicated symptomatic genital infection
These antibiotics can clear symptomatic S. pyogenes genital infection. Adult evidence comes mainly from case reports and culture-based observations, rather than randomized treatment trials or measurements with this quantitative panel. Published reports describe symptom resolution and, in some antibiotic-treated cases, subsequent negative genital cultures. A reliable percentage reduction in this panel's number hasn't been established. [Adult case review](https://pubmed.ncbi.nlm.nih.gov/21336834/), [Adult culture series](https://pmc.ncbi.nlm.nih.gov/articles/PMC11462322/).
MedicationStrong Evidence
↓ Decrease
Amoxicillin plus rifampin to eradicate documented carriage in both partners after recurrent genital infection
In one case report, recurrent genital infection stopped after the affected woman and her husband received eradication treatment for documented carriage. Earlier treatment of the woman alone had been followed by recurrence. This supports investigating a possible shared source in recurrent confirmed infection, but it doesn't establish how often partner treatment helps or justify treating every partner after a first positive swab. The study used cultures and strain identification, not this quantitative panel. [Case report](https://doi.org/10.1016/j.ijid.2014.07.026).
MedicationStrong Evidence

Frequently Asked Questions

Panels containing Streptococcus pyogenes

Streptococcus pyogenes is included in these pre-built panels.

References

18 studies
  1. H. Verstraelen, R. Verhelst, M. Vaneechoutte, M. TemmermanArchives of Gynecology and Obstetrics2011
  2. S. Ederaine, R. Torgerson, M. L. MarnachInternational Journal of Women's Dermatology2022
  3. C. Amores-antequera, a. Delgado-baena, P. Parrado-hernando, P. Cantudo-muñoz, L. Velasco-rodríguezRevista Española De Quimioterapia2024
  4. E. Verkaeren, L. Epelboin, S. Epelboin, N. Boddaert, F. Brossier, E. CaumesInternational Journal of Infectious Diseases2014